Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132616) titled 'Clinical evaluation of bispectral index -guided closed-loop target-controlled infusion of ciprofol in patients with lung tumors' on Sept. 16.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The Fourth Hospital of Hebei Medical University
Condition:
lung tumor
Intervention:
Group ciprofol: bispectral index -guided closed-loop target-controlled infusion of ciprofol
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-09-30
Target Sample Size: Group ciprofol:100;Group profol:100;
Countries of Recruitment:
China
To know more, visit https://www.chictr.o...